Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BDNF-TPN
- Development stage
- Preclinical
- Lead developer
- University of Toronto
- Modality
- Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
BDNF-TPN is an investigational, blood-brain-barrier-permeable terpolymer nanoparticle formulation that delivers brain-derived neurotrophic factor to the central nervous system. It was developed in an academic preclinical program for Alzheimer's disease to protect BDNF during systemic circulation and improve neuronal delivery after intravenous administration. In APP transgenic Alzheimer's disease mouse models, BDNF-TPN produced neuroprotective signaling, reduced neuroinflammation and neuronal apoptosis, increased synaptic-plasticity markers, and improved hippocampal-dependent contextual learning relative to vehicle and free BDNF. ([advanced.onlinelibrary.wiley.com](https://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202501648))
02
Targets
NTRK2 (Tropomyosin-related kinase receptor type B)
Beyond the preview
Go deeper on BDNF-TPN.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BDNF-TPN.